Overview

A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
To establish the bioequivalence between Glucobay ODT (Orally Disintegrating Tablet) taken without or with water and the Glucobay standard tablet taken with water
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Acarbose